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Introduction 
Pleural effusion is a commonly encountered medical problem. Its clinical and radiological features
often fail to identify the underlying cause. Pleural fluid aspiration and needle biopsy of pleura are
initial diagnostic procedures to ascertain the aetiology of effusion. Both these procedures are performed
under local anaesthesia and cariy a low risk of complication. Being a blind procedure, adequate pleura
may not be obtained with needle biopsy. The diagnostic yield of pleural biopsy varies according to the
underlying disease as well as the number of biopsies taken1. In our study, we have assessed (a) yield of
adequate tissue in needle biopsy of pleura; (b) number in which the histology was diagnostic, (c)
complications of biopsy and (d) results of histology in comparison with pleural aspirate. Finally we
have suggested a guideline for investigation of pleural effusion.
Patients and Methods 
Records of all patients at the Aga Khan University Hospital who underwent pleural biopsy between
May, 1991 and December, 1992 were reviewed. Clinical history, chest radiograph, characteristics of
pleural fluid and histology of pleural biopsy were recorded and analyzed.
Results 
Total of 68 patients (Male:Female = 1.8:1) underwent pleural biopsy. Age range was 16-89 years
(Mean 48 years). Thirty-two (47%) patients had a co-existent medical disorder, the three commonest
being ischemic heart disease, cirrhosis and diabetes. Seven (10%) gave a previous histoiy of
tuberculosis. Effusion was right sided in 34 (50%), left sided in 27 (40%) and bilateral in 7 (10%).
Effusion was small in 16 (24%), moderate in 32 (47%) and massive in 20 (29%) patients. Pleural fluid
characteristics are presented in Table I.
Haemorrhagic effusion was noted in 16 patients; of these 4 (25%) had TB and 9 (56%) malignancy. In
the remaining 3 patients, no definite cause was found. Pleural biopsy was perfonned either by Abraham
or Cope Needle. Adequate pleura was obtained in 57 (84%) patients. Histology was diagnostic in 31
(46%) biopsies, being TB in 21 and malignancy in 10 patients. The final diagnoses based on clinical
features and investigation is presented in Table II.
It was observed that patients with an initial suspicion of TB may prove to have malignancy and vice
versa. Upto half of the patients suspected to have parapneumonic effusion actually hadTB or
malignancy.  In patients under3Oyears of age, effusionwas causedby TB in 62% of cases. Malignancy
was seen mainly above 30 years of age but TB remained equally important cause of effusion in this age
group as well. TB produced lymphocytic effusion in 97% of cases. Malignant effusion was also mostly
(80%) lymphocytic. Therefore, lymphocytic predominance alone cannot differentiate between TB and
malignancy. Etiology in 6 (12%) lymphocytic effusion remained uncertain. Complications of pleural
biopsy occurred in 10 (15%) patients, being asymptomatic pneumothorax in 6, surgical emphysema in
3 and inadvertent liver biopsy in 1 patient. There was no mortality associated with the procedure.
Discussion 
Pleural effusion can resultfroma large variety of causes. Transudate is caused by a limited number of
conditions such as cardiac failure and hypoalbuminemia and clinical evaluationusuálly reveals the
primary cause. Exudative effusion on the other hand has diverse etiologies and the cause of effusion is
not clear at times even after a thorough clinical evaluation and basic investigations e.g., blood counts,
chest radiograph and sputum examination. The two common conditions causing exudative effusion
which often need to be differentiated are TB and malignancy. It is in these patients that pleural fluid
aspiration and pleural biopsy is performed. The diagnostic yield of these procedures varies greatly in
different studies. Ourstudy has shownthatone isunlikely to findacidfastbacilli onZiehl Neelsen stainof
pleural fluid. When the fluid was sent for culture, not only one had to wait for several weeks for results,
the culture was positive in only a very small number of cases. Inoculation of pleural fluid into the
culture medium at bedside rather than in laboratory has been shown to significantly increase the culture
yield2. Bactec system, which is a radiometric assay system to detect growth of mycobacterium
tuberculosis, gives the results of culture much faster than convential mycobacterial culture (18 versus
33 days) 2. Newer diagnostic tests are being developed to increase the diagnostic yield of tuberculosis.
Adenosine deaminase, an enzyme found in T lymphocyte, is markedly elevated in tuberculous effu-
sion3. Similarly Gamma interferon4 and soluble interleukin 2 receptor level5 were found to be higher in
tuberculous effusion as comparedto malignant effusion. ELISA methods have been able to detect tiny
amounts of mycobacterial antigen in body fluids, the technique had the advantage of being rapid,
sensitive and specific6. In malignant pleural effusion cytology is positive in 33-72% cases. Increased
levels of carcinoembyoine antigen (CEA) is found in adenocaminoma7. Similarly elevated levels of
hyaluromc acid is found in malignant mesothelioma8 and of neurone specific enolase in small cell
carcinoma9. The common primary tumors causing malignant effusion are adenocarcinoma of lung,
lymphoma and carcinoma of breast, ovary and pancreas. Closed pleural biopsy is indicated if cause of
exudative pleural effusion remains undiagnosed even after pleural fluid analysis. In tuberculous
effusion, where culture is positive in less than 15% of cases, closed pleural biopsy increases the
diagnostic yield to over 80%10. In malignant effusion, on the other hand, cytology alone is positive in
upto 70% of cases11. Needle pleural biopsy is usually performed by Abrahams or Cope Needle and
there is no significant difference in their diagnostic yield12. Trucut needle has also been found to be
useful and safe13. Needle pleural biopsy has been found to be generally safe, though asymptomatic
pneumothorax may occur in upto 10% of cases. Isolated case reports of more serious complications
(e.g., arteriovenous fistula) has been reported14. The cause of pleural effusion may remain undiagnosed
in 20% patients even after pleural biopsy and in these thoracoscopy is recommended to differentiate
between malignant and benign effusion15. Fiberoptic bronchoscopy is unlikely to be helpful in the
diagnosis of lone pleural effusion16. Our study has shown that nearly 50% of the cases of pleural
effusion in our community were tuberculous and 25% were malignant. Yield of mycobactena was
extremely low in pleural fluid whereas cytology was positive in over 60% of malignant effusions.
Needle biopsy of pleura was found to be a safe procedure and was specially useful in the diagnosis of
tuberculosus effusion. Inlightofourpresent study and review ofotherprevious studies we suggest the
following protocol for investigation of pleural effusion when the cause is not apparent clinically
(Figure).
Pleural fluid aspiration and analysis should initially be performed. Zeihl Neelsenstainis usually
recommendedbut we question its value as it is invariably negative. TB culture is positive in only a
small number of patients, but when positive, is very valuable as it identifies the organism and gives the
drug sensitivity. Pleural fluid amylase should be measured if pancreatitis, oesophageal rupture or
malignancy is suspected. Newer techniques for detection of biochemical, immune and malignant
markers and for detection of mycobactenal antigen would be helpful when available. If initial results of
pleural fluid analysis are inconclusive and the fluid is an exudate then repeat thoracocentesis with
multiple closed pleural biopsy should be performed. The biopsy should be sent both for histopathology
and TB culture. By this stage diagnosis is likely to be established in upto 80% of cases. In the
remaining undiagnosed cases thoracoscopy with guided biopsy can be performed. If the diagnosis still
remains in doubt, then a decision needs to be taken on individual case to case basis, whether to simply
follow the patient or to perform open thorâcotomy and biopsy.
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